相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Criteria to define interruption of transmission of human cytomegalovirus from organ donor to recipient
Ilona Anna Baraniak et al.
REVIEWS IN MEDICAL VIROLOGY (2018)
A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor
Flavio Vincenti et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia
Ilona Baraniak et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
Camille N. Kotton et al.
TRANSPLANTATION (2018)
Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation
Ceri A Fielding et al.
eLife (2017)
Cytomegalovirus Vaccines: Current Status and Future Prospects
K. M. Anderholm et al.
DRUGS (2016)
Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial
David I. Bernstein et al.
VACCINE (2016)
The pathogenesis of human cytomegalovirus
Paul Griffiths et al.
JOURNAL OF PATHOLOGY (2015)
Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy
S. F. Atabani et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial
Mohamed A. Kharfan-Dabaja et al.
LANCET INFECTIOUS DISEASES (2012)
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
Paul D. Griffiths et al.
LANCET (2011)
Vaccine Prevention of Maternal Cytomegalovirus Infection
Robert F. Pass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Incidence of cytomegalovirus infection among the general population and pregnant women in the United States
Fernando A. B. Colugnati et al.
BMC INFECTIOUS DISEASES (2007)
Vaccine development to prevent cytomegalovirus disease: Report from the National Vaccine Advisory Committee
AM Arvin et al.
CLINICAL INFECTIOUS DISEASES (2004)
Encouraging prospects for immunisation against primary cytomegalovirus infection
PD Griffiths et al.
VACCINE (2001)
分享论文
